Alpha Real Trust (ARTL) Share Price, News & Analysis

Company Overview

Alpha Real Trust Limited specializes in investments in securities, services, and other related businesses. The fund seeks to invest in the United Kingdom and Europe.

Key Stats

• Today's Range: 178.50 to 203
• 50-Day Range: 108.50 to 202.50
• 52-Week Range: 108 to 205
• Volume: 5.12 million shs
• Average Volume: 411,522 shs
• Market Capitalization: £122.07 million
• P/E Ratio: N/A
• Dividend Yield: 1.98%
• Price Target: N/A
• Consensus Rating: N/A

ARTL Stock Analysis - Frequently Asked Questions

How have ARTL shares performed this year?

Alpha Real Trust's stock was trading at GBX 201.62 at the beginning of 2025. Since then, ARTL stock has increased by 0.4% and is now trading at GBX 202.50.
View the best growth stocks for 2025 here.

How do I buy shares of Alpha Real Trust?

Shares of ARTL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Alpha Real Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Alpha Real Trust investors own include AIkido Pharma (AIKI), AMC Entertainment (AMC), Advanced Micro Devices (AMD), A10 Networks (ATEN), Skillz (SKLZ), Tilray (TLRY) and Aurora Cannabis (ACB).

Company Calendar

• Ex-Dividend for 10/25 Dividend: 9/26/2024
• Dividend Payable: 10/25/2024
• Ex-Dividend for 1/24 Dividend: 12/05/2024
• Today: 1/21/2025
• Dividend Payable: 1/24/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Pharmaceutical Products
• Current Symbol: LON:ARTL
• CUSIP: N/A
• CIK: N/A
• Web: www.alpharealtrustlimited.com
• Phone: +44-20-75911615
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £1.28 million
• Net Margins: -10.07%
• Pretax Margin: N/A
• Return on Equity: -0.75%
• Return on Assets: 1.74%

Debt

• Debt-to-Equity Ratio: 6.57
• Current Ratio: 62.73
• Quick Ratio: 31.39

Sales & Book Value

• Annual Sales: £9.23 million
• Price / Sales: 13.23
• Cash Flow: GBX 116.49 per share
• Price / Cash Flow: 1.74
• Book Value: GBX 207 per share
• Price / Book: 0.98

Miscellaneous

• Outstanding Shares: 60,280,000
• Free Float: N/A
• Market Cap: £122.07 million
• Optionable: Not Optionable
• Beta: 0.28